Transcriptome analysis reveals GA induced apoptosis in HCT116 human colon cancer cells through calcium and p53 signal

Chen Yang1,2,3, Xiaoyu Xie4, Hu Tang1,2,3

  • 1Oil Crops Research Institute, Chinese Academy of Agricultural Sciences Wuhan 430062 P. R. China yangchen@caas.cn huangfh@oilcrops.cn.

RSC Advances
|May 11, 2022
PubMed

Insights

Gallic acid (GA) induces colon cancer cell death by triggering apoptosis. This polyphenol down-regulates calcium channels and up-regulates the p53 pathway, ultimately activating the mitochondrial apoptosis pathway.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Gallic acid (GA), a natural polyphenol, exhibits anticancer properties, including apoptosis induction in cancer cell lines.
  • The precise mechanisms by which GA induces apoptosis remain largely unelucidated.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying gallic acid-induced apoptosis in human colon cancer HCT116 cells.
  • To identify key genes and pathways affected by GA treatment using transcriptomic analysis.

Main Methods:

  • RNA sequencing (RNA-seq) was employed to analyze gene expression changes in HCT116 cells after 12 and 24 hours of GA exposure.
  • KEGG pathway enrichment analysis was performed to identify significantly altered biological pathways.
  • Real-time quantitative PCR (RT-qPCR) was utilized to validate RNA-seq findings.

Main Results:

  • GA treatment significantly altered the expression of 792 genes at 12 hours and 911 genes at 24 hours.
  • Enriched pathways included cholinergic synapse, circadian entrainment, calcium signaling, arachidonic acid metabolism, and the p53 signaling pathway.
  • GA treatment led to the down-regulation of calcium channels and subsequent up-regulation of the p53 signaling pathway.

Conclusions:

  • Gallic acid effectively triggers apoptosis in HCT116 colon cancer cells.
  • The mechanism involves initial cell growth obstruction via calcium channel down-regulation, followed by p53 pathway activation and caspase-mediated mitochondrial apoptosis.
  • GA represents a potential therapeutic agent for colon cancer, warranting further investigation.